Triple
T10292302
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | human adenovirus serotype 26 |
E241391
|
entity |
| Predicate | developerOfVectorPlatform |
P92934
|
FINISHED |
| Object | Janssen Vaccines |
E248879
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Janssen Vaccines | Statement: [human adenovirus serotype 26, developerOfVectorPlatform, Janssen Vaccines]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Janssen Vaccines Context triple: [human adenovirus serotype 26, developerOfVectorPlatform, Janssen Vaccines]
-
A.
Janssen Pharmaceuticals
chosen
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
B.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
C.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: developerOfVectorPlatform Context triple: [human adenovirus serotype 26, developerOfVectorPlatform, Janssen Vaccines]
-
A.
gameDevelopmentPlatform
Indicates a platform or environment used for creating, developing, and possibly deploying games.
-
B.
gameDeveloper
Indicates that one entity creates, designs, or develops the other entity, which is a game.
-
C.
developerStudio
Indicates that a software developer or development team is associated with, works at, or uses a particular development studio or integrated development environment (IDE).
-
D.
majorDeveloper
Indicates that an entity is a primary or leading developer responsible for creating or significantly contributing to another entity.
-
E.
developmentArc
Indicates the progression and transformation of something over time, typically outlining key stages of growth, change, or maturation within a broader narrative or process.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381aaafc08190af475ef58dc16aba |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d4d2d35f048190a215493acdf1f718 |
completed | April 7, 2026, 9:48 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d7500fdd1c81909395469afb346f8b |
completed | April 9, 2026, 7:06 a.m. |
| PD | Predicate disambiguation | batch_69d4d1f35e548190be3b4d92d65d2d20 |
completed | April 7, 2026, 9:44 a.m. |
| PDg | Predicate description generation | batch_69d4d29d7cf08190acd70cee634c5cdb |
completed | April 7, 2026, 9:47 a.m. |
Created at: April 6, 2026, 11:42 a.m.